Key Findings Underscore Persistent Morbidity of BPPV

The study, conducted at a tertiary referral center, aimed to answer a critical clinical question: what are the long-term rates of recurrence, residual dizziness, falls, and quality-of-life impairment after successful treatment of BPPV? The findings offer a stark reminder that BPPV is not merely a transient ailment for many.

Bottom Line Summary:

  • Recurrence: Nearly half of patients (47.1%) experienced BPPV recurrence within seven years.
  • Residual Dizziness: Over one-third of patients (37.6%) reported ongoing dizziness long after the initial treatment phase.
  • Fall Risk: Residual symptoms were strongly associated with an increased likelihood of falls.
  • Disability: Dizziness-related disability, as measured by the Dizziness Handicap Inventory, was significantly higher in patients with recurrence or residual symptoms.

Background: Understanding the Impact of BPPV

Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, characterized by brief, intense episodes of dizziness and nausea triggered by changes in head position. It is typically caused by displaced otoconia (calcium carbonate crystals) within the inner ear’s semicircular canals. Canal-specific repositioning maneuvers, such as the Epley maneuver or the Semont maneuver, are highly effective in resolving the acute symptoms by returning these crystals to their proper location.

However, the success of these maneuvers in the short term does not always translate to a complete absence of long-term consequences. Some patients report persistent imbalance or a feeling of unsteadiness, even after the vertigo episodes have ceased. This lingering imbalance, or residual dizziness, can significantly affect daily activities, potentially leading to a fear of movement, social withdrawal, and a heightened risk of falls, particularly among older adults who are already more vulnerable. The study’s focus on long-term outcomes provides crucial data for clinicians and patients to better anticipate and manage these persistent challenges.

Study Design and Methodology

The research employed an ambispective cohort study design, a robust methodology that combines retrospective data collection with prospective follow-up. This approach allowed researchers to analyze historical treatment data and then track the same patient cohort forward in time, providing a comprehensive view of long-term outcomes.

Setting:
The study was carried out at a tertiary referral center, a specialized hospital equipped to handle complex medical cases, indicating that the patient population may have included individuals with more challenging or persistent BPPV presentations.

Patient Cohort:
Between May 2011 and March 2017, a total of 361 patients diagnosed with BPPV were included in the study. The cohort comprised individuals with a mean age of 63.3 years, with women making up a significant majority at 69%. The posterior semicircular canal was identified as the most commonly affected in 86.7% of the cases, which is consistent with general epidemiological data for BPPV.

Chronology of BPPV Treatment and Follow-Up

The study meticulously tracked patients through their treatment journey and beyond:

  • Initial Treatment: In the initial phase, 63.4% of patients experienced complete resolution of their vertigo after just one repositioning maneuver. However, a substantial 36.6% required two or more maneuvers to achieve symptom relief. This distinction in treatment intensity proved to be a significant predictor of future complications.
  • One-Month Follow-Up: A critical early indicator of potential long-term issues emerged one month after symptom resolution. At this juncture, 29.6% of patients reported experiencing residual disequilibrium. Among these individuals, 30 underwent further evaluation with computerized dynamic posturography (CDP), a test measuring balance and stability, and subsequently participated in vestibular rehabilitation programs.
  • Long-Term Follow-Up (Seven Years): The study’s comprehensive seven-year follow-up provided the most striking insights into the enduring impact of BPPV.
    • Recurrence: A significant 47.1% of patients experienced at least one recurrence of BPPV within this timeframe.
    • Nature of Recurrence: In an overwhelming 87% of recurrent cases, the same semicircular canal that was initially affected was involved, suggesting a potential underlying susceptibility or incomplete resolution of the initial cause.
    • Residual Dizziness Persistence: The prevalence of residual dizziness, initially noted at one month, remained a persistent issue, affecting 37.6% of patients at the long-term follow-up.

Supporting Data: Unpacking the Risk Factors and Associations

The study’s detailed analysis uncovered several key associations between initial treatment characteristics, residual symptoms, and long-term adverse outcomes.

Factors Associated with Recurrence:

  • Multiple Repositioning Maneuvers: Patients who required two or more maneuvers during their initial BPPV episode were significantly more likely to experience recurrence. The odds ratio (OR) for recurrence in this group was 3.89 (P=0.033), indicating nearly four times the likelihood compared to those who resolved after one maneuver.
  • Vestibular Rehabilitation: Similarly, patients who underwent vestibular rehabilitation following their initial episode also faced higher odds of recurrence (OR, 2.41; P=0.022). This association might suggest that vestibular rehabilitation was prescribed for patients with more complex or persistent initial symptoms, which could also predispose them to recurrence.

Factors Associated with Long-Term Residual Dizziness:

  • Persistent Instability: The presence of residual dizziness after the initial treatment was a strong predictor of long-term instability. Patients reporting residual dizziness had substantially higher odds of experiencing persistent long-term instability (OR, 4.88; P<0.001), nearly five times the likelihood.
  • Initial Treatment Intensity: Requiring multiple repositioning maneuvers during the initial BPPV episode was also linked to a higher likelihood of developing long-term residual dizziness (OR, 2.06; P=0.049).

Association with Falls:

  • Residual Dizziness as a Major Risk Factor: The study identified residual dizziness as a significant contributor to falls. Patients experiencing residual dizziness had significantly higher odds of reporting falls (OR, 5.70; P=0.017), a more than five-fold increase.
  • Vestibular Rehabilitation and Fall Risk: Interestingly, patients who underwent vestibular rehabilitation also demonstrated higher odds of falling (OR, 3.70; P=0.007). This finding, similar to the recurrence data, may reflect that vestibular rehabilitation was often indicated for individuals with more pronounced balance deficits, which inherently increase fall risk.

Quality of Life Impairment:

  • Dizziness Handicap Inventory (DHI) Scores: The impact of BPPV on patients’ lives was quantified using the Dizziness Handicap Inventory (DHI), a widely used questionnaire assessing the impact of dizziness on daily functioning. Patients who experienced recurrence, residual symptoms, or a combination of both, consistently reported higher DHI scores compared to those who remained asymptomatic. This indicates a significant decline in their quality of life due to the persistent effects of the condition.

Analysis of Implications: Beyond Acute Vertigo

The findings of this extensive study carry significant implications for clinical practice, patient education, and future research in the management of BPPV.

Rethinking Long-Term Management:
The substantial rates of recurrence and residual dizziness highlight the need for a more proactive and long-term approach to BPPV management. While acute symptom resolution is the primary goal, clinicians should be vigilant for lingering effects and educate patients about the potential for recurrence.

Risk Stratification:
The identification of factors like the number of maneuvers required for initial treatment as predictors of recurrence and residual dizziness allows for better risk stratification. Patients identified as high-risk could benefit from closer monitoring, more tailored patient education, and potentially earlier intervention with vestibular rehabilitation.

The Role of Vestibular Rehabilitation:
The study’s findings regarding vestibular rehabilitation and its association with recurrence and falls warrant careful consideration. It suggests that while vestibular rehabilitation can be beneficial, its prescription should be carefully considered, perhaps as a targeted intervention for specific balance deficits rather than a routine follow-up for all BPPV patients. The data implies that the indication for vestibular rehabilitation itself may be a marker for a more complex underlying vestibular dysfunction that predisposes to ongoing issues.

Fall Prevention:
The strong link between residual dizziness and increased fall risk underscores the critical importance of addressing these persistent symptoms. For older adults, falls can lead to serious injuries, hospitalization, and a decline in independence. Therefore, strategies to mitigate residual dizziness are paramount for fall prevention in this vulnerable population.

Patient Education and Support:
Understanding the long-term trajectory of BPPV can empower patients. Comprehensive patient education should include information about potential recurrence, the possibility of residual symptoms, and the importance of reporting any ongoing unsteadiness. Support groups and resources that address the psychological impact of chronic dizziness could also be invaluable.

Future Research Directions:
This study opens avenues for further investigation. Future research could explore the underlying biological mechanisms contributing to recurrence and residual symptoms, investigate novel therapeutic approaches to prevent or manage these long-term effects, and conduct cost-effectiveness analyses of various management strategies. Further studies could also delve deeper into the specific types of vestibular deficits that persist and how they can be most effectively targeted.

Conclusion: A Persistent Challenge Beyond Initial Relief

The study by Martin-Sanz and colleagues unequivocally demonstrates that benign paroxysmal positional vertigo is not always a self-limiting condition. Despite the effectiveness of immediate treatment maneuvers, a significant proportion of patients face ongoing challenges, including recurrent episodes and persistent dizziness. These residual symptoms are not benign; they are strongly linked to an increased risk of falls and a diminished quality of life. This research serves as a critical reminder for healthcare providers to maintain a long-term perspective when managing BPPV, emphasizing proactive assessment, comprehensive patient education, and targeted interventions to mitigate the enduring impact of this common vestibular disorder.

Citation: Martin-Sanz E, et al. Long-term benign paroxysmal positional vertigo: recurrence, residual symptoms and risk of falls. Otolaryngol Head Neck Surg. 2026;175:119-125. doi:10.1002/ohn.70257